These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27639619)

  • 21. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
    Kumar A; Roy S; Tripathi S; Sharma A
    J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational dynamics of cathepsin D and binding to a small-molecule BACE1 inhibitor.
    Ellis CR; Tsai CC; Lin FY; Shen J
    J Comput Chem; 2017 Jun; 38(15):1260-1269. PubMed ID: 28370344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
    Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational insights into the protonation states of catalytic dyad in BACE1-acyl guanidine based inhibitor complex.
    Kocak A; Erol I; Yildiz M; Can H
    J Mol Graph Model; 2016 Nov; 70():226-235. PubMed ID: 27770745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the protonation state for the catalytic dyad in β-secretase when bound to hydroxyethylamine transition state analogue inhibitors: A molecular dynamics simulation study.
    Gueto-Tettay C; Pestana-Nobles R; Drosos-Ramirez JC
    J Mol Graph Model; 2016 May; 66():155-67. PubMed ID: 27111489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
    Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH
    Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target specific proteochemometric model development for BACE1 - protein flexibility and structural water are critical in virtual screening.
    Manoharan P; Chennoju K; Ghoshal N
    Mol Biosyst; 2015 Jul; 11(7):1955-72. PubMed ID: 25927726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study on the active mechanism of β-secretase inhibitors by molecular simulations.
    Tian YL; Lv M; Li JJ; Xu T; Zhai HL; Zhang XY
    Eur J Pharm Sci; 2015 Aug; 76():138-48. PubMed ID: 25965961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The selective BACE1 inhibitor VIa reduces amyloid-β production in cell and mouse models of Alzheimer's disease.
    Cheng X; Zhou Y; Gu W; Wu J; Nie A; Cheng J; Zhou J; Zhou W; Zhang Y
    J Alzheimers Dis; 2013; 37(4):823-34. PubMed ID: 23948917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoimidazoles as potent and selective human beta-secretase (BACE1) inhibitors.
    Malamas MS; Erdei J; Gunawan I; Barnes K; Johnson M; Hui Y; Turner J; Hu Y; Wagner E; Fan K; Olland A; Bard J; Robichaud AJ
    J Med Chem; 2009 Oct; 52(20):6314-23. PubMed ID: 19757823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of human BACE2 in complex with a hydroxyethylamine transition-state inhibitor.
    Ostermann N; Eder J; Eidhoff U; Zink F; Hassiepen U; Worpenberg S; Maibaum J; Simic O; Hommel U; Gerhartz B
    J Mol Biol; 2006 Jan; 355(2):249-61. PubMed ID: 16305800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and molecular insights into tacrine-benzofuran hybrid induced inhibition of amyloid-β peptide aggregation and BACE1 activity.
    Kaur R; Narang SS; Singh P; Goyal B
    J Biomol Struct Dyn; 2023; 41(22):13211-13227. PubMed ID: 37013977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual inhibition of BACE1 and Aβ aggregation by β-ecdysone: Application of a phytoecdysteroid scaffold in Alzheimer's disease therapeutics.
    Chakraborty S; Basu S
    Int J Biol Macromol; 2017 Feb; 95():281-287. PubMed ID: 27871792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unravelling the molecular basis of AM-6494 high potency at BACE1 in Alzheimer's disease: an integrated dynamic interaction investigation.
    Ugbaja SC; Appiah-Kubi P; Lawal MM; Gumede NS; Kumalo HM
    J Biomol Struct Dyn; 2022 Aug; 40(12):5253-5265. PubMed ID: 33410374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bennett acceptance ratio method to calculate the binding free energy of BACE1 inhibitors: Theoretical model and design of new ligands of the enzyme.
    Gutiérrez M; Vallejos GA; Cortés MP; Bustos C
    Chem Biol Drug Des; 2019 Jun; 93(6):1117-1128. PubMed ID: 30693676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Novel BACE1 Inhibitors by Combination of Pharmacophore Modeling, Structure-Based Design and In Vitro Assay.
    Ju Y; Li Z; Deng Y; Tong A; Zhou L; Luo Y
    Curr Comput Aided Drug Des; 2016; 12(1):73-82. PubMed ID: 26899408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and thermodynamic characteristics of the exosite binding pocket on the human BACE1: a molecular modeling approach.
    Gutierrez LJ; Enriz RD; Baldoni HA
    J Phys Chem A; 2010 Sep; 114(37):10261-9. PubMed ID: 20806954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.
    Malamas MS; Erdei J; Gunawan I; Turner J; Hu Y; Wagner E; Fan K; Chopra R; Olland A; Bard J; Jacobsen S; Magolda RL; Pangalos M; Robichaud AJ
    J Med Chem; 2010 Feb; 53(3):1146-58. PubMed ID: 19968289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural insight into the mechanism of amyloid precursor protein recognition by β-secretase 1: A molecular dynamics study.
    Chakraborty S; Basu S
    Biophys Chem; 2015 Jul; 202():1-12. PubMed ID: 25863345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rational Design of Dual Inhibitors for Alzheimer's Disease: Insights from Computational Screening of BACE1 and GSK-3β.
    Sai Varshini M; Reddy RA; Krishnamurthy PT; Selvaraj D
    Curr Comput Aided Drug Des; 2024; 20(6):998-1012. PubMed ID: 37921183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.